Reduced protection of RIPK3-deficient mice against influenza by matrix protein 2 ectodomain targeted active and passive vaccination strategies

• Teodora Oltean,
• Lorena Itati Ibanez,
• Tatyana Divert,
• Tine Ysenbaert,
• Hannelore Van Eeckhoutte,
• Vera Goossens,
• Michael Schotsaert,
• Ken Bracke,
• Bert Schepens,
• Jonathan Maelfait,
• Nozomi Takahashi,
• Xavier Saelens,
• Peter Vandenabeele

Affiliations

Teodora Oltean

VIB-UGent, Center for Inflammation Research (IRC)

Lorena Itati Ibanez

VIB-UGent Center for Medical Biotechnology, VIB

Tatyana Divert

VIB-UGent, Center for Inflammation Research (IRC)

Tine Ysenbaert

VIB-UGent Center for Medical Biotechnology, VIB

Hannelore Van Eeckhoutte

Laboratory for Translational Research in Obstructive Pulmonary Diseases, Dept of Respiratory Medicine, Ghent University Hospital

Vera Goossens

VIB Screening Core & UGent Expertise Centre for Bioassay Development and Screening (C-BIOS)

Michael Schotsaert

VIB-UGent Center for Medical Biotechnology, VIB

Ken Bracke

Laboratory for Translational Research in Obstructive Pulmonary Diseases, Dept of Respiratory Medicine, Ghent University Hospital

Bert Schepens

VIB-UGent Center for Medical Biotechnology, VIB

Jonathan Maelfait

VIB-UGent, Center for Inflammation Research (IRC)

Nozomi Takahashi

VIB-UGent, Center for Inflammation Research (IRC)

Xavier Saelens

VIB-UGent Center for Medical Biotechnology, VIB

Peter Vandenabeele

VIB-UGent, Center for Inflammation Research (IRC)